Literature DB >> 8048835

Octreotide treatment associated with adrenal suppression and poor feeding.

J K Wales.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8048835      PMCID： PMC1029888          DOI： 10.1136/adc.70.6.553-a

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  3 in total

1.  Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin).

Authors:  C Invitti; M de Martin; A Brunani; M Piolini; F Cavagnini
Journal:  Clin Endocrinol (Oxf)       Date:  1990-03       Impact factor: 3.478

2.  Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy.

Authors:  B Glaser; H J Hirsch; H Landau
Journal:  J Pediatr       Date:  1993-10       Impact factor: 4.406

3.  Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.

Authors:  B Ambrosi; D Bochicchio; C Fadin; P Colombo; G Faglia
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256
  3 in total
  1 in total

1.  Successful treatment of congenital chylous ascites with a somatostatin analogue.

Authors:  M G Caty; M L Hilfiker; R G Azizkhan; P L Glick
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.